[1] 姜维,侯疏影,谷宏伟.水飞蓟素对酒精性脂肪肝患者肝功能和血脂水平的影响[J].中国中医药科技,2011(5):376.
[2] Gao B,Bataller R.Alcoholic liver disease:pathogenesis and new therapeutic targets[J].Gastroenterology,2011,141(5):1572-1585.
[3] Sung H,Kim SW,Hong M,et al.Microbiota-based treatments in alcoholic liver disease[J].World J Gastroenterol.2016,22(29):6673-6682.
[4] 唐峥,尹然,毕开顺,等.栀子大黄汤血清药物化学的初步研究[J].中草药,2014,45(23):3377-3382.
[5] 陈科霖.栀子大黄汤对ANIT诱导的肝内胆汁淤积大鼠的保护作用及其药效物质研究[D].沈阳:沈阳药科大学,2014.
[6] 周琼.小鼠急性肝损伤模型的建立及GSTA1分析[D].哈尔滨:东北农业大学,2012.
[7] 陆新烈,袁建芬,徐建立,等.大黄酸对非酒精性脂肪性肝病大鼠肝脏病理组织学及超微结构变化的影响[J].中国中医药科技, 2013(5):477-478.
[8] 张超.栀子柏皮汤对α-萘异硫氰酸酯致大鼠肝损伤的保护作用[J].时珍国医国药,2013(8):1862-1864.
[9] Bailey SM,Cunningham CC.Contribution of mitochondria to oxidative stress associated with alcoholic liver disease[J].Free Radical Bio Med,2002,32(1):11-16.
[10] Wu D,Cederbaum AI.Oxidative stress and alcoholic liver disease[J].Alcohol Health Res World,1997,21(4):321-324.
[11] Ezquer F,Bruna F,Calligaris SN,et al.Multipotent mesenchymal stromal cells:A promising strategy to manage alcoholic liver disease[J].World J Gastroenterol,2016,22(1):24-36.
[12] Tilg H,Moschen AR,Szabo G.Interleukin-1 and inflammasomes in alcoholic liver disease/acute alcoholic hepatitis and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis[J].Hepatology,2016,64(3):25-28.
[13] Park B,Lee HR,Lee YJ.Alcoholic liver disease:Focus on prodromal gut health[J].J Digest Dis,2016,17(8):184-195.
[14] Rao R.Endotoxemia and gut barrier dysfunction in alcoholic liver disease.[J].Hepatology,2009,50(2):638-644.
[15] Albano E.Oxidative mechanisms in the pathogenesis of alcoholic liver disease[J].Mol Aspects Med,2008,29(1):9-16.
[16] Zintzaras E,Stefanidis I,Santos M,et al.Do alcohol-metabolizing enzyme gene polymorphisms increase the risk of alcoholism and alcoholic liver disease?[J].Hepatology,2006,43(2):352-361.
[17] 李欣昕,陈林飞,欧阳永中,等.栀子大黄汤对酒精性肝损伤保护作用的质谱评价[J].中国药科大学学报,2015,28(5):579-586.
[18] 范建高,颜士岩.代谢综合征与脂肪肝[J].临床肝胆病杂志,2016,32(3):407-410. |